Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single industry-sponsored agreement in the school’s history.
Read More
Lewis sat down with IBJ to talk about his leadership style and the role of cycling in his life.
Read More
Elanco opened the doors of its new headquarters at the former GM stamping plant site this week.
Read More
As chief operating officer, Severns oversees 14 offices at 11 sites, including the new Carmel facility on Illinois Street, that treat roughly 900 patients a day.
Read More
House Enrolled Act 1004, passed in 2023, required the Indiana Department of Insurance to contract with a third party to calculate how Indiana’s nonprofit hospital systems’ commercial prices compared to Medicare reimbursements over time.
The new hire will replace interim CEO John Bowen on April 1.
Orna is developing a treatment known as CAR-T cell therapy, a form of immunotherapy that trains a person’s own cells to recognize and destroy diseases.
Jenn Wells, an executive at the Greenfield-based health care system, is trying to make difficult conversations more accessible through a women’s health podcast she started last fall called “Just Jenn.”
The animal health startup had fundraising success in 2025, a year in which investment deals were hard to come by.
Eli Lilly and Co. shares soared in midday trading Wednesday after the drugmaker reported fourth-quarter results that topped Wall Street expectations.
Eli Lilly and Co. has announced $50 billion in U.S. expansion commitments since 2020, including numerous manufacturing plants all over the country.
There is an unlimited amount of health information, from vaccines to mental health, on the internet and social media, and an ever-increasing number of people are creating it and searching for it.
Libris Innovations was created to help the Indiana Biosciences Research Institute advance the nonprofit’s scientific discoveries into new companies dedicated to delivering medical innovations for patients in need.
The new facility, part of a $27 billion reshoring investment, will produce the drugmaker’s weight-loss therapies.
The agreement with Seamless is the latest in a series of purchases and partnerships Lilly has established to build a pipeline of genetic medicines.
The Center for AI and Robotic Excellence in Medicine in part seeks to grow knowledge of AI and its uses in medicine and to identify solutions to military and frontier care challenges.
Rural hospitals are among those that are most affected by the financial challenges facing health care institutions in Indiana, according to a new report released by the Indiana Hospital Association.
The Indianapolis-based radiopharmaceutical company built a 150,000-square-foot production facility and plans to add up to jobs.
The new hire succeeds Ernest Vargo II, who retired Jan. 15 after serving as CEO for 15 years.
The fund has secured commitments from Eli Lilly and Co., Corteva Inc., Elanco Animal Health, Indiana University, Parkview Health and the Indiana Economic Development Corp.
Ovarian cancer is the fifth-leading cause of cancer death among women in the United States.
The $435 million campus will include more than 500,000 square feet of advanced laboratory and production space.
During Irwin’s time with Community, the Foundation has raised more than $137 million in donations to be distributed to programs across Community Health Network.
U.S. Food and Drug Administration officials say a comprehensive review “found no increased risk” related to suicide among users of the GLP-1 drugs, including Eli Lilly and Co.’s Zepbound, used to treat obesity.
